On Thursday, Merck & Co Inc (NYSE: MRK) topped estimates with its fourth quarter revenue and adjusted earnings fueled by its blockbuster cancer drug Keytruda, along with HPV prevention vaccine Gardasil. However, Merck still recorded a net quarterly loss due to charges that resulted from a deal to co-develop three after-cancer treatments with a Japanese drugmaker Daiichi Sankyo. But, Merck’s patent for Keytruda is expiring in 2028 so it needs more products under its belt. Like its peers, Moderna
Several UK patients have received a revolutionary cancer vaccine as part of a global trial. Scientists are using the mRNA technology used to make the Covid vaccine to create new vaccines that can treat and even cure cancer.
From Kristen Dahlgren stepping away from NBC to focus on the Pink Eraser Project for cancer vaccines, to MTV’s Jared March dying of sarcoma, here’s what is happening in the oncology space this week.